David J. Lloyd

4 Patents

• US124656522025

  Method of Treating or Ameliorating Metabolic Disorders Using Antagonistic Binding Proteins for Gastric Inhibitory Peptide Receptor (GIPR)/GLP-1 Receptor Agonist Fusion Proteins

  AMGEN Inc.

  0 cites
• US124351492025

  Method of Treating or Ameliorating Metabolic Disorders Using Binding Proteins for Gastric Inhibitory Peptide Receptor (GIPR) in Combination with GLP-1 Agonists

  AMGEN Inc.

  0 cites
• US122525402025

  Nucleic Acid Molecules Encoding Binding Proteins for Gastric Inhibitory Peptide Receptor (GIPR)

  Amgen Inc.

  0 cites
• US120604302024

  Nucleic Acid Molecules Encoding Binding Proteins for Gastric Inhibitory Peptide Receptor (GIPR)

  Amgen Inc.

  0 cites